non transplant treatments for mds & secondary aml (co-chair summary)
Published 6 years ago • 889 plays • Length 8:11Download video MP4
Download video MP3
Similar videos
-
9:29
non-transplant treatment for mds
-
4:26
treatments for mds and secondary aml part 1, low-risk mds
-
34:15
from mds to aml: what every patient needs to know 11/28/17
-
55:36
ash 2020: aml secondary to mds - updates for patients
-
1:13:29
understanding higher risk mds and transtion to aml
-
1:34:48
non-transplantation for bone marrow failure
-
45:07
the old and the new in mds management
-
24:29
myelodysplastic syndrome
-
56:48
molecular genetics of mds/mpn overlap syndromes
-
3:23
alternative donor transplantation for mds/aml
-
10:41
myelodysplastic syndrome (mds) - what is the treatment?
-
6:50
the role of bmt in treatment-related mds and aml
-
15:18
myelodysplastic syndrome (mds)
-
1:01:45
new and emerging therapies for mds
-
1:24
can early treatment for mds prevent progression to aml? #aml
-
1:27:22
outcomes for high-risk mds patients undergoing transplant vs standard non-transplant therapies
-
1:00:43
mds transformation to aml
-
25:33
mds – new and emerging treatments
-
0:43
when might a transplant be considered in mds? #aml
-
12:43
transplant treatments for bone marrow failure
-
1:09
differences and similarities between mds and aml & how this can inform treatment decisions
-
1:39
how likely is it that mds will progress to aml? and how long does it usually take? #aml